HAI Pathogens and Antimicrobial Resistance Report Data Tables, 2018-2021

Pediatric Data Tables

Print
PAGE 5 of 11

‹View Table of Contents

Related Pages

Table P4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type, Pediatrics, 2018-2021

Table P4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type, Pediatrics, 2018-2021
NICUs
(n=698 hospitals)		 Pediatric Oncology Units1
(n=111 hospitals)		 Pediatric ICUs2
(n=247 hospitals)		 Pediatric Wards3
(n=263 hospitals)
Pathogen # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank #
Pathogens		 % Pathogens Rank # Pathogens % Pathogens Rank
Staphylococcus aureus 1,346 27.2 1 281 6.2 5 511 13.6 2 324 12.6 2
Coagulase-negative staphylococci 931 18.8 2 545 12.1 2 428 11.4 3 217 8.5 4
Escherichia coli 593 12.0 3 530 11.8 3 172 4.6 9 214 8.3 5
Enterococcus faecalis4 511 10.3 4 225 5.0 6 553 14.8 1 238 9.3 3
Select Klebsiella spp. 375 7.6 5 440 9.8 4 389 10.4 4 346 13.5 1
Candida albicans4 196 4.0 6 35 0.8 17 106 2.8 11 70 2.7 11
Enterobacter spp. 167 3.4 7 193 4.3 8 275 7.3 5 171 6.7 6
Serratia spp. 148 3.0 8 36 0.8 16 188 5.0 7 107 4.2 9
Pseudomonas aeruginosa 144 2.9 9 217 4.8 7 178 4.8 8 97 3.8 10
Other Candida spp.4 114 2.3 10 162 3.6 9 241 6.4 6 131 5.1 8
Group B streptococci 98 2.0 11 15 0.3 29 16 0.4 19 8 0.3 25
Acinetobacter spp. 28 0.6 12 42 0.9 15 46 1.2 13 32 1.2 14
Candida glabrata4 25 0.5 13 22 0.5 22 21 0.6 16 21 0.8 17
Citrobacter spp. 23 0.5 14 30 0.7 19 22 0.6 15 31 1.2 15
Enterococcus faecium4 22 0.4 15 130 2.9 10 109 2.9 10 49 1.9 12
Other pathogen 224 4.5 1,595 35.5 490 13.1 511 19.9
Total 4,945 100.0 4,498 100.0 3,745 100.0 2,567 100.0

Note: Refer to Technical Resources for more information about the acronyms and terms used in this table.

Footnotes:

  1. Some rankings are not shown: Viridans group streptococci (#1, 15.1%); Other Enterococcus (#11, 1.9%); Rothia mucilaginosa (#12, 1.8%); Granulicatella adiacens (#13, 1.4%); Stenotrophomonas maltophilia (#14, 1.2%).
  2. Some rankings are not shown: Stenotrophomonas maltophilia (#12, 1.9%); Other Enterococcus (#14, 1.2%).
  3. Some rankings are not shown: Viridans group streptococci (#7, 5.3%); Other Enterococcus (#13, 1.4%).
  4. When analyzed at the genus-level, Candida and Enterococcus spp. resulted in the following rankings:
    1. Candida – NICUs (#6, 6.8%); oncology units (#7, 4.9%); ICUs (#5, 9.8%); wards (#4, 8.6%).
    2. Enterococcus – NICUs (#4, 11.0%); oncology units (#5, 9.8%); ICUs (#1, 18.9%); wards (#3, 12.6%).

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Pediatric HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Pediatric HAIs
  2. Table P1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. Table P2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table P3: The Top 15 HAI Pathogens Reported to NHSN
  5. ›Table P4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. Table P5. The Top 15 CAUTI Pathogens Reported to NHSN
  7. Table P6. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  8. Table P7. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  9. Table P8. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  10. Table P9. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats
  11. Table P10. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for High-volume Surgical Categories